Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis.
CONCLUSION: The presented data suggest that pregabalin primarily acts on neuronal Ca2+ channel trafficking thereby reducing Ca2+-mediated cytotoxicity and neuronal damage in an animal model of MS. Future clinical trials need to assess the benefit for neuronal survival by expanding the indication for pregabalin administration to MS patients in further disease phases.
PMID: 30481775 [PubMed - as supplied by publisher]
Source: Neuro-Signals - Category: Neurology Authors: Hundehege P, Fernandez-Orth J, Römer P, Ruck T, Müntefering T, Eichler S, Cerina M, Epping L, Albrecht S, Menke AF, Birkner K, Göbel K, Budde T, Zipp F, Wiendl H, Gorji A, Bittner S, Meuth SG Tags: Neurosignals Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Brain | Calcium | Clinical Trials | Epilepsy | Learning | Lyrica | Men | Multiple Sclerosis | Neurology | Pain | Study | Universities & Medical Training